↓ Skip to main content

Dove Medical Press

Treatment of glioblastoma multiforme cells with temozolomide-BioShuttle ligated by the inverse Diels-Alder ligation chemistry

Overview of attention for article published in Drug Design, Development and Therapy, January 2009
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (87th percentile)
  • Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

patent
13 patents

Citations

dimensions_citation
33 Dimensions

Readers on

mendeley
31 Mendeley
Title
Treatment of glioblastoma multiforme cells with temozolomide-BioShuttle ligated by the inverse Diels-Alder ligation chemistry
Published in
Drug Design, Development and Therapy, January 2009
DOI 10.2147/dddt.s3572
Pubmed ID
Authors

Klaus Braun, Manfred Wiessler, Volker Ehemann, Ruediger Pipkorn, Herbert Spring, Juergen Debus, Bernd Didinger, Mario Koch, Gabriele Muller, Waldemar Waldeck

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 31 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Denmark 1 3%
Canada 1 3%
Brazil 1 3%
Unknown 28 90%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 7 23%
Student > Bachelor 5 16%
Professor 4 13%
Student > Master 4 13%
Researcher 2 6%
Other 4 13%
Unknown 5 16%
Readers by discipline Count As %
Chemistry 9 29%
Biochemistry, Genetics and Molecular Biology 5 16%
Medicine and Dentistry 4 13%
Agricultural and Biological Sciences 4 13%
Pharmacology, Toxicology and Pharmaceutical Science 2 6%
Other 2 6%
Unknown 5 16%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 18 March 2020.
All research outputs
#3,798,945
of 25,374,917 outputs
Outputs from Drug Design, Development and Therapy
#249
of 2,268 outputs
Outputs of similar age
#18,274
of 183,286 outputs
Outputs of similar age from Drug Design, Development and Therapy
#2
of 9 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,268 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.1. This one has done well, scoring higher than 88% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 183,286 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 87% of its contemporaries.
We're also able to compare this research output to 9 others from the same source and published within six weeks on either side of this one. This one has scored higher than 7 of them.